Choline kinase: A novel target for antitumor drugs

IDrugs

Volumn 4, Issue 4, 2001, Pages 419-426

  Lacal, Juan Carlos ^a  

^a CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001715433     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Wittenberg J, Komberg A: Choline phosphokinase. J Bid Chem (1953)202(1):431-444.
2. Hosaka K, Kodak! T, Yamashita S: Cloning and characterization of the yeast CKI gene encoding choline kinase and its expression in Escherichia coll. J Biol Chem (19B9) 264(4):2053-2059. • This manuscript describes the cloning of the first choline kinase gene. It opened the way for further characterization of the enzyme and the cloning of choline kinase mammalian genes.
3. Uchida T, Yamashita S: Molecular cloning, characterization, and expression in Escherichia coli of a cDNA encoding mammalian choline kinase. J Biol Chem (1992) 304(14):10156-10162.
4. Hosaka K, Tanaka S, Nkawa J, Yamashita S: Cloning of a human choline kinase cDNA by complementation of the yeast ckl mutation. FEBS Lett (1992) 267(2-3):229-232. •• This paper reports the cloning of the human choline kinase gene and its characterization. It provided the critical tool for further development of those reagents critical for understanding the role of choline kinase in carcinogenesis.
5. Monks DE, Goode JH, Dewey RE: Characterization of soybean choline kinase cDNAs and their expression in yeast and Escherichia coli. Plant Physio! (1996) 110(4): 1197-1205.
6. Porter TJ, Kent C: Purification and characterization of choline/ethanolamine kinase from rat liver. J Biol Chem (1990) 265(1):414-422.
7. Pelech SL, Vance DE: Regulation of phosphatidylcholine biosynthesis. Biochem BiophysActa (1984) 779:217-251.
8. Kim KH, Voelker DR, Flocco MT, Carman GM: Expression, purification, and characterization of choline kinase, product of the CKI gene from Saccharomyces cerevisiae. J Biol Chem (1998) 273(12):6844-6852.
9. Uchida T, Yamashita S: Choline/ethanolamine kinase from rat brain. Methods Enzymol(W92) 209:147-153.
10. Zeisel SH, DaCosta K-A, Franklin PD, Alexander EA, Lamont JT, Sheard NF, Beiser A: Choline, an essential nutrient for humans. FASEB J(1991) 5:2093-2098.
11. Lacal JC, Moscat J and Aaronson SA: Novel source of 1,2diacylglicerol elevated in cells transformed by Ha-ras oncogene: Nature (1987) 330:269-271. • The authors demonstrated that elevated levels of DAG in ras-transformed cells were generated not by the hydrolysis of Pi-containing phospholipids, but from the hydrolysis of phosphatidylcholine. The paper also provided the basis for a better understanding of the role of the lipid-derived metabolites in mitogenic signaling after transformation by Pas oncoproleins.
12. Lacal JC: Diacylglycerol production in Xenopus laevls oocytes after microinjection of p21ras proteins is a consequence of activation of phosphatidylcholine metabolism. Mol Cell Biol (1990) 10: 333-340.
13. Macara IG: Elevated phosphocholine concentration in ras-transformed NIH3T3 cells arises from increase choline kinase activity, not from phosphatidylcholine breakdown. Mol Cell Bio (1989) 9:325-328.
14. Camera A, Lacal JC: Phospholipase-induced maturation of Xenopus laevis oocytes: mitogenic activity of generated metabolites. J Cell Biochem (1993) 52:440-448.
15. Camera A, Cuadrado A, del Peso L, Lacal JC: Activation of type D phospholipase by serum and ras-induced transformation in NIH3T3 cells. Oncogens (1994) 9:1387-1395.
16. Camera A, Dolfi F, Lacal JC: Ras-p21 activates phospholipase D and A2, but no phospholipase C or PKC, In Xenopus laevis oocytes. J Cell Biochem (1994) 54:478-486.
17. Lacal JC, Camera A: Regulation of Ras proteins and their involvement in signal transduction pathways. Oncol Rep (1994) 1:677-693.
18. Camera A, Lacal JC: Activation of intracellular kinases in Xenopus laevis oocytes by ras-p21 and phospholipases: a comparative study. Mol Cell Biol (1995) 15:1094-1101.
19. Lacal JC: Regulation of proliferation and apoptosis by Ras and R ho GTPases through specific phospholipid-dependent signaling. F£BSJ.efl(1997) 410:73-77.
20. del Peso L, Hemândez R, Esteve P, Lacal JC: Activation of phospholipase D by Ras proteins is independent of protein kinase C. J Cell Biochem (1996) 61:599-608.
21. del Peso L, Lucas L, Esteve P, Lacal JC: Activation of phospholipase D by growth factors and oncogenes in murine fibroblasts follow alternative but cross-talking pathways. Biochem J (1997) 322:519528.
22. Lucas L, del Peso L, Rodriguez P, Penalva V, Lacal JC: Ras protein is involved in the physiological regulation of phospholipase D by platelet derived growth factor. Oncogens (2000) 19:431-437.
23. Guynn RW: Equilibrium constants under physiological conditions for the reaction of choline kinase and the hydrolysis of phosphorylcholine to choline and inorganic phosphate. J Biol Chem (1976) 251(22):7162-7167.
24. Pelech SL, Vance DE: Signal transduction via phosphatidylcholine cycles. Trends Biochem Sc/(1989) 14:28-30. ;
25. Billah MM, Anthes JC: The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J(1990) 269:281-291.
26. Zeisel SH: Choline phospholipids: signal transduction and carcinogenesis. FASEB J (1993) 7:551-557.
27. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (1992) 258:607-614.
28. Agwu DE, McPhail LC, Chabot MC, Daniel LW, Wykle RL, McCall CE: Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils. J Biol Chem (1989) 264:1405-1413.
29. Moolenaar WH, Kruijer W, Tilly BC, Werlaan I, Bierman AJ, de Laat SW: Growth factor-like action of phophatidic acid. Wa/ure(1986) 323:171-173.
30. Rameh LE, Cantley LC: The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem (1999) 274(13):8347-8350.
31. Cuadrado A, Camera A, Dolfi F, Jiménez B, Lacal JC. Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. Oncogene (1993) 8:2959-2968. • This paper provided the first time demonstration of the mitogenic activity of PCho, establishing a link between growth factor- and oncogene-induced cell proliferation. The study also provided the basis for oncogene-driven transformation as a consequence of an unbalance of lipid metabolites:
32. Jiménez B, del Peso L, Montaner S, Esteve P, Lacal JC: Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-Kinases in growth factors-induced mitogenic stimulation. J Cell Biochem (1995) 57:141-149.
33. Hemandez-Alcoceba R, Saniger L, Campos J, Nunez MC, Khaless F, Gallo MA, Espinosa A, Lacal JC: Choline kinase inhibitors as a novel approach for antiproliferatvie drug design. Oncogene (1997) 15:2289-2301. •• This paper provided solid experimental evidence for the possible use of choline kinase inhibitors as novel antitumor drugs. It demonstrates that non-tumorigenic cells are less sensitive to choline kinase inhibitors than their rastranstomned counterparts.
34. Kiss Z, Chung T: Choline phosphate and phorfool ester potentiate the mltogenic effect of insulin by competitive mechanisms in NIH3T3 cells. Blochem Biophys Res Commun (1996) 218:505-509.
35. Chung T, Crilly KS, Anderson WH, Murherjee JJ, Kiss Z: ATPdependent choline phosphate-Induced mitogenesis in fibroblasts involves activation of pp70 S6 kinase and phosphatidyiinositol 3'kinase through an extracellular site. J Biol Chem (1997) 272(5):3064-3072.
36. Upreti RK: Influence of choline and ethanolamine administration on choline and ethanolamine phosphorylating activities of mouse liver and kidney. Can JBiochem( 1979) 57(7):981-985.
37. Millington WR, Wurtman 'RJ: Choline administration elevates brain phosphorylcholine concentrations. JNeurochem(i982) 38(6): 1748-1752.
38. McUaster'cR, Bel! RM: Phosphatidylcholine biosynthesis via the CDP-choline pathway in Saccharomyces cerevisiae. Multiple mechanisms of regulation. J Biol Chem (1994) 269(20):14776-14783
39. Warden CH, Friedkin M: Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J Biol Chem (1985) 260(10):6006-6011.
40. Vigo C, Paddon HB, Millard FC, Pritchard PH, Vance DE: Diethylstilbestrol treatment modulates the enzymatic activities of phosphatidylcholine biosynthesis in rooster. Biochim Biophys Acta (1981)665(3):546-550.
41. Paddon HB, Vigo C, Vance DE: Diethylstilbestrol treatment increases the amount of choline kinase in rooster liver. Biochim Biophys Acta (1982) 710(1):112-115.
42. Ko KW, Cook HW, Vance DE: Reduction of phosphatidylcholine turnover In a Nb 2 lymphoma cell line after prolactin treatment. A novel mechanism for control of phosphatidylcholine levels in cells. JB/o/C/iem(1986)261(17):7846-7852.
43. Man AS, Lee E, Choy PC: Biphasic modulation of choline uptake and phosphatidylcholine biosynthesis by vasopressin in rat cardiac myocytes. U'pids (1994) 29(1):15-19.
44. Uchida T: Stimulation of phospholipid synthesis in HeLa cells by epidermal growth factor and insulin: activation of choline kinase and glycerophosphate acyltransferase. Biochim Biophys Acta (1996) 1304(2):89-104.
45. Hundertmark S, Lorenz U, Weitzel HK, Ragosch V: Effect of epidermal growth factor on enzymes of phospholipid biosynthesis in lung and liver of fetal rat In vivo and In vitro. Horn Metab Res ( 1999) 31 ( 1 ):8-13.
46. Kim K-H, Carman GM. Phosphorylation and regulation of choline kinase from Saccharomyces cerevisiae by protein kinase A. J Biol Chem (1999) 274(14):9531-9538. •• This manuscript provides the first evidence for a regulation of choline kinase by phosphorylatlon, in contrast to the 'classical' mechanism of regulation of its synthesis. It is also important because it places choline kinase downstream of Ras in the S Cerevisiae system.
47. Wieprecht M, Wieder T, Geilen CC: W-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulphonamide (H-89) inhibits incorporation of choline into phosphatidylcholine via inhibition of choline kinase and has no effect on the phosphorylation of CTP: phosphocholine cytidylyltransferase. Biochem J (1994) 297:241-247.
48. Uchida T: Immunologically and enzymatically distinct rat choline kinase isozymes. J Biochem (1994) 116(6):1241-1250.
49. Tadokoro K, Ishidate K, Nakazawa Y: Evidence for the existence of isozymes of choline kinase and their selective induction in 3methylcholanthrene- or carbon tetrachtoride-treated rat liver. Biochim Biophys Acta (1985) 835(3):501-513.
50. Uchida T: Regulation of choline kinase R: analysis of alternatively spliced choline kinases and the promoter region. J Biochem (1994) 116:508-518.
51. Teegarden D, Taparowsky EJ, Kent C:'Altered phosphatidylcholine . metabolism in C3H10T1/2 cells transfected with the Harvey-ras oncogene. J Biol Chem (1990) 265:6042-6047.
52. Momchilova A, Markovska T, Pankov R: Ha-ras-transformation alters the metabolism of phosphatidylethanolamine and phosphatidylcholine in NIH 3T3 fibroblasts. Cell Blol Int (1999) 23(9):603-610.
53. Ratnam S, Kent C: Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. Arch Biochem Biophys (1995) 323:313-322.
54. Bhakoo KK, ' Williams SR, Florian CL, Und H, Noble M: Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res (1996) 56:4630-4635. • This manuscript demonstrates a dear correlation between an increase in PCho levels and transformation in human tumors. Furthermore, it demonstrates that this is independent of cell proliferation status. It establishes solid grounds for the analysis, by NMR, of the levels of PCho in human tumors as a valid diagnostic strategy to correlate with the transforming phenotype.
55. Nakagami K, Uchida T, Ohwada S, Koibuchi Y, Suda Y, Sekine T, Morishita Y: Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res (1999)90:419-124. • This work demonstrates that choline kinase is elevated both in terms of enzyme amounts and activity in human colorectal tumors. However, no correlation with the specific stage of the tumor or its prognosis is reported.
56. Ruiz-Cabello J, Cohen JS: Phospholipid metabolites as indicators of cancer cell function. NMR Biomed (1992) 5:226-233.
57. 21P MRS of experimental tumours. NMR Biomed(1993) 6:345-365.
58. Smith TAD, Bush C, Jameson C, Titley JC, Leach MO, Wilman DEV, McCready VR: Phospholipid metabolites, prognosis and proliferation in human breast carcinoma. NMR Biomed(1993) 6:318-323.
59. Ishidate K, Tsuruoka M, Nakazawa Y: Induction of choline kinase by polycyclic aromatic hydrocarbon carcinogens in rat liver. Biochem Biophys Res Commun (1980) 96(2):946-952. • First demonstration that choline kinase is increased after carcinogen treatment in rats. A correlation between increased choline kinase activity and the process of carcinogenesis in whole animals is established.
60. Nakagami K, Uchida T, Ohwada S, Koibuchi Y, Morishita Y: Increased choline kinase activity in 1,2-dimethylhydrazine-induced rat colon cancer. Jpn J Cancer Res (1999) 90(11):1212-1217.
61. Chung T, Huang J, Mukherjee JJ, Crilly KS, Kiss Z: Expression of human choline kinase in NIH 3T3 fibroblasts increases the mitogenic potential of insulin and insulin-like growth factor I. Cell Signal (2000) 12(5):279-288.
62. Hemândez-Alcoceba R, Femândez F, Laçai JC: A novel mechanism for anticancer drug discovery: In vivo antitumor activity by Inhibition of phsphorylcholine production. Cancer Res (1999) 59:3112-3110. •• This study demonstrates that choline kinase Inhibitors are potent antitumor drugs in vivo against human-derived tumor cells.
63. Ancelin ML, Vial HJ: Several lines of evidence demostrating that Plasmodium faleiparum, a parasitic organism, has distinct enzymes for the phosphorylation of choline and ethanolamine. FEBS Lett (1986) 202(2):217-223.
64. Ishidate K: Choline Transport and Choline Kinase. In: Phospholipid Metabolism. DE Vance (Ed), CRC Press, Florida (1989):9-23
65. Bariow P, Marchbanks RM: Effect of ethyl choline mustard on choline dehydrogenase and other enzymes of choline metabolism. J Neurochem (1984) 43(6): 1568-1573.
66. Clary GL, Tsai CF, Guynn RW: Substrate specificity of choline kinase. Arch Biochem Biophys (1987) 254(1):214-221.
67. Khatri JN, Silks LA 3rd, Kosh JW: Selected pharmacodynamic and biochemical properties of selenonium choline. Gen Pharmacol (1998)30(1):95-101.
68. Barlow P, Marchbanks RM: Effect of ethyl choline mustard on choline dehydrogenase and other enzymes of choline metabolism. J Neurochem (1984) 43(6): 1568-1573.
69. Chu AJ: Mechanism by which ethanol inhibits phosphatidylcholine biosynthesis in human leukemic monocyte-like U937 cells. Cell Biochem Fun (1994) 12(1):45-55.
70. Sandberg K, Schnaar RL, McKinney M, Hanin l, Fisher A, Coyle JT: AF64A: an active site directed irreversible inhibitor of choline acetyltransferase. JWeurochem(1985) 44(2):439-445.
71. Reinhard! RR, Wecker L, Cook PF: Kinetic mechanism of choline kinase from rat striata. JB/o/C/iem(1984) 259(12):7446-7452.
72. Crilly KS, Tomono M, Kiss Z: The choline kinase inhibitor hemlcholinium-3 can inhibit mitogen-induced DNA synthesis independent of its effect on phosphocholine formation. Arch Biochem Biophys (1995) 352(1):137-143.
73. Ishidate K, Nakazawa Y: Choline/ethanolamine kinase from rat kidney. Methods Enzymol (\992) 209:121-134.
74. Ando M, Iwata M, Takahama K, Nagata Y: Effects of extracellular choline and K depolarization on choline kinase and choline acetyltransferase activities in superior cervical synpathetic ganglia excised from rats. JNeurochem (1987) 48(5):1448-1453.
75. Zha X, Jay FT, Choy PC: Effects of amino acids and ethanolamine on choline uptake and phosphatidylcholine biosynthesis in baby hamster kidney-21 cells. Biochem Cell Biol (1992)70(12):1319-1324.
76. Kaldany RR, Kariin A: Reaction of quinacrine mustard with the acetylcholine receptor from Torpedo californica. J Biol Chem (1983) 258(10):6232-6242.
77. Wecker L, Reinhard! RR: Adenosine inhibits choline kinase activity and decreases the phosphorylation of choline in striatal synaptosomes. J Neurochem (1988) 50(6): 1945-1951.
78. Singh Y, Chaudhary VK, Tyagi SR, Misra UK: Inhibition of hepatic phosphatidylcholine synthesis by malathion in rats. Toxicol Lett (1984)20(2):219-223.
79. Just l, Falke D: Inhibition of giant cell formation by Compound 4880 after infection with herpesvirus hominis. IV. Compound 48-80, an inhibitor of choline kinase activity. Arch Gesamte Virusforsch (1974) 46(1-2):140-147.
80. Mayer D, Wemer D: Inhibition of choline kinase by selectively cytotoxic purinyI-6-histamine. Biochem Pharmacol (1974) 23(7):1227-1230.
81. Sasi PK, Kaleysa RR: Effect of piperazine on the level of phospholipids and on the activities of certain enzymes of phospholipid metabolism in human Ascaris lumbricoldes. Experienf/a(1975)31{11):126M262.
82. Ansell GB. Spanner SG: The inhibition of brain choline kinase by hemicholinium-3. J Neurochem (W74) 22(6):1153-5
83. LJoveras J, Hamza M, Chap H, Douste-Blazy L: Action of hemicholinium-3 on phospholipid metabolism in Krebs II ascites cells. Biochem Pharmacol (1985) 34(22):3987-3993.
84. Spanner S, Ansell GB: Choline kinase and ethanolamine kinase activity in the cytosol of nerve endings from rat forebrain. Biochem J(1979)178(3):753-760.
85. Cannon JG: Structure-activity aspects of hemicholinium-3 (HC-3) and its analogues and congeners. Med Res Rev (1994) 14(5):505531. Excellent review that provides full information on the structure and properties of the choline kinase inhibitor hemicholinium-3 and its derivatives.
86. Campos J, Nünez MC, Rodriguez V, Gallo MA, Espinosa A: QSAR of 1,V-(1,2-ethylenebisbenzyl)bis{4-substituted pyridinium) dibromides as choline kinase inhibitors: a different approach for antiproliferative drug design. Biorg Med Chem (2000) 10(8):767-770.
87. Campos J, Nunez MC, Rodriguez V, Entrena A, Gallo MA, HemândezAlcoceba R, Femândez F, Laçai JC, Espinosa A: LU MO Energy of model compounds as an index for the inhibition of choline kinase: chemical meaning. Eur J Med Chem (2001) In press.
88. Crilly KS, Tomono M, Kiss Z: The choline kinase inhibitor hemicholinium-3 can inhibit mitogen-induced DNA synthesis independent of its effect on phosphocholine formation. Arch Biochem Biophys (1998) 352(1):137-143.
89. Ramirez de Molina A. Rodriguez-Gonzälez A, Penalva V, Lucas L, Lacal JC: Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten- and N-ras transformed cells. Submitted.